Aurora Cannabis (ACB) Consolidated Net Income (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Consolidated Net Income of -$56.0 million for Q1 2026, down 615.22% year-over-year from $10.9 million in Q1 2025, and down 48722.05% quarter-over-quarter from -$114733.8 in Q4 2025.
Aurora Cannabis (ACB) Consolidated Net Income (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Consolidated Net Income for 10 consecutive years, with -$56.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Consolidated Net Income fell 615.22% year-over-year to -$56.0 million; the TTM figure through Mar 2026 stood at -$56.4 million (up 99.61% YoY), while the FY2026 annual figure was -$56.4 million, down 207.96% from the prior year.
- Consolidated Net Income slipped to -$56.0 million in Q1 2026 per ACB's latest filing, from -$114733.8 in the prior quarter.
- Across five years, Consolidated Net Income topped out at $304.0 million in Q2 2024 and bottomed at -$14.6 billion in Q3 2024.
- Historically, Consolidated Net Income has averaged -$1.6 billion across 5 years, with a median of -$4.6 million in 2022.
- Annual changes were most pronounced in 2023 — Consolidated Net Income sank 590811.34% — and 2024, when it surged 110.76%.
- Aurora Cannabis' Consolidated Net Income stood at -$13.4 million in 2022, then soared by 94.27% to -$765386.0 in 2023, then soared by 110.76% to $82322.7 in 2024, then slumped by 239.37% to -$114733.8 in 2025, then slumped by 48722.05% to -$56.0 million in 2026.
- Business Quant data shows ACB's Consolidated Net Income at -$56.0 million in Q1 2026, -$114733.8 in Q4 2025, and $84289.7 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Aurora Cannabis | 234.38 Mn | 162.07 Mn | 25.75 Mn | -2.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.02 Mn |
| Dec 31, 2025 | -114,733.81 |
| Sep 30, 2025 | 84,289.66 |
| Jun 30, 2025 | -349,308.85 |
| Mar 31, 2025 | -7.83 Mn |
| Dec 31, 2024 | 82,322.65 |
| Sep 30, 2024 | -14.64 Bn |
| Jun 30, 2024 | 304.00 Mn |
| Mar 31, 2024 | -371,798.72 |
| Dec 31, 2023 | -765,386.02 |
| Sep 30, 2023 | -2.57 Bn |
| Jun 30, 2023 | -8.13 Bn |
| Dec 31, 2022 | -13.35 Mn |
| Sep 30, 2022 | -10.19 Mn |
| Jun 30, 2022 | -1.38 Mn |
| Mar 31, 2022 | -799.25 Mn |
| Dec 31, 2021 | -59.91 Mn |
| Sep 30, 2021 | -9.61 Mn |
| Jun 30, 2021 | 613,399.48 |
| Mar 31, 2021 | -130.19 Mn |